Davenport & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.05M Buy
5,048
+380
+8% +$154K 0.01% 497
2025
Q1
$2.32M Buy
4,668
+562
+14% +$280K 0.01% 443
2024
Q4
$2.14M Sell
4,106
-76
-2% -$39.5K 0.01% 453
2024
Q3
$2.59M Sell
4,182
-1
-0% -$619 0.01% 416
2024
Q2
$2.31M Sell
4,183
-81
-2% -$44.8K 0.01% 417
2024
Q1
$2.48M Buy
4,264
+83
+2% +$48.2K 0.02% 390
2023
Q4
$2.22M Buy
4,181
+202
+5% +$107K 0.02% 386
2023
Q3
$2.01M Sell
3,979
-92
-2% -$46.6K 0.02% 371
2023
Q2
$2.12M Sell
4,071
-172
-4% -$89.7K 0.02% 372
2023
Q1
$2.45M Buy
4,243
+8
+0.2% +$4.61K 0.02% 348
2022
Q4
$2.33M Buy
4,235
+124
+3% +$68.3K 0.02% 345
2022
Q3
$2.09M Sell
4,111
-193
-4% -$97.9K 0.02% 343
2022
Q2
$2.34M Sell
4,304
-81
-2% -$44K 0.02% 339
2022
Q1
$2.59M Buy
4,385
+76
+2% +$44.9K 0.02% 353
2021
Q4
$2.88M Buy
4,309
+134
+3% +$89.4K 0.02% 338
2021
Q3
$2.39M Buy
4,175
+270
+7% +$154K 0.02% 355
2021
Q2
$1.97M Buy
3,905
+605
+18% +$305K 0.02% 336
2021
Q1
$1.51M Buy
3,300
+118
+4% +$53.9K 0.01% 326
2020
Q4
$1.48M Buy
3,182
+262
+9% +$122K 0.01% 318
2020
Q3
$1.29M Buy
2,920
+137
+5% +$60.5K 0.01% 302
2020
Q2
$1.01M Sell
2,783
-152
-5% -$55.1K 0.01% 330
2020
Q1
$832K Buy
2,935
+243
+9% +$68.9K 0.01% 325
2019
Q4
$875K Buy
2,692
+154
+6% +$50.1K 0.01% 364
2019
Q3
$745K Hold
2,538
0.01% 378
2019
Q2
$745K Buy
2,538
+343
+16% +$101K 0.01% 377
2019
Q1
$601K Buy
2,195
+105
+5% +$28.7K 0.01% 388
2018
Q4
$468K Buy
2,090
+383
+22% +$85.8K 0.01% 411
2018
Q3
$417K Buy
1,707
+25
+1% +$6.11K ﹤0.01% 480
2018
Q2
$348K Buy
1,682
+274
+19% +$56.7K ﹤0.01% 527
2018
Q1
$291K Buy
1,408
+100
+8% +$20.6K ﹤0.01% 559
2017
Q4
$248K Sell
1,308
-58
-4% -$11K ﹤0.01% 603
2017
Q3
$258K Sell
1,366
-77
-5% -$14.6K ﹤0.01% 575
2017
Q2
$252K Buy
+1,443
New +$252K ﹤0.01% 573